The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

Doctors are currently using stem cells to treat a variety of medical conditions — and that list could soon become even larger ...